Bortezomib, Lenalidomide plus low-dose dexamethasone compared with Lenalidomide plus low-dose dexamethasone in the treatment of newly diagnosed multiple myeloma: prospective randomized phase III trial. - AdisInsightBortezomib, Lenalidomide plus low-dose dexamethasone compared with Lenalidomide plus low-dose dexamethasone in the treatment of newly diagnosed multiple myeloma: prospective randomized phase III trial.Drugs Bortezomib (Primary) ; Aciclovir; Aspirin; Dexamethasone; Lenalidomide; Zoledronic acid
